Type 2 diabetes

E Ahmad, S Lim, R Lamptey, DR Webb, MJ Davies - The Lancet, 2022 - thelancet.com
Type 2 diabetes accounts for nearly 90% of the approximately 537 million cases of diabetes
worldwide. The number affected is increasing rapidly with alarming trends in children and …

5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes—2023

NA ElSayed, G Aleppo, VR Aroda, RR Bannuru… - Diabetes …, 2023 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …

5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes—2024

Diabetes Care, 2024 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …

[HTML][HTML] Clinical insights into the cross-link between mood disorders and type 2 diabetes: a review of longitudinal studies and Mendelian randomisation analyses

C Possidente, G Fanelli, A Serretti, C Fabbri - … & Biobehavioral Reviews, 2023 - Elsevier
Mood disorders and type 2 diabetes mellitus (T2DM) are prevalent conditions that often co-
occur. We reviewed the available evidence from longitudinal and Mendelian randomisation …

Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management

M Berk, O KöhlerForsberg, M Turner… - World …, 2023 - Wiley Online Library
Populations with common physical diseases–such as cardiovascular diseases, cancer and
neurodegenerative disorders–experience substantially higher rates of major depressive …

Depression, diabetes, comorbid depression and diabetes and risk of all-cause and cause-specific mortality: a prospective cohort study

R Prigge, SH Wild, CA Jackson - Diabetologia, 2022 - Springer
Aims/hypothesis The aim of this study was to investigate the risks of all-cause and cause-
specific mortality among participants with neither, one or both of diabetes and depression in …

[HTML][HTML] Anti-inflammatory medications for the treatment of mental disorders: a scoping review

R Fitton, J Sweetman, W Heseltine-Carp… - Brain, Behavior, & …, 2022 - Elsevier
This scoping review assessed the effect of anti-inflammatory medications in mental
disorders. A search in Medline and the Cochrane database focusing on randomised …

Efficacy and safety of antidepressants in patients with comorbid depression and medical diseases: an umbrella systematic review and meta-analysis

O Köhler-Forsberg, V Stiglbauer, J Brasanac… - JAMA …, 2023 - jamanetwork.com
Importance Every third to sixth patient with medical diseases receives antidepressants, but
regulatory trials typically exclude comorbid medical diseases. Meta-analyses of …

Glucagon-like peptide 1 receptor activation inhibits microglial pyroptosis via promoting mitophagy to alleviate depression-like behaviors in diabetic mice

F Yang, X Wang, J Qi, K Zhang, Y Jiang, B Feng, T Lv… - Nutrients, 2022 - mdpi.com
Depression is a frequent and serious comorbidity associated with diabetes which adversely
affects prognosis and quality of life. Glucagon-like peptide-1 receptor (GLP-1R) agonists …

Antidepressants for depressed patients with type 2 diabetes mellitus: A systematic review and network meta-analysis of short-term randomized controlled trials

M Srisurapanont, S Suttajit, N Kosachunhanun… - Neuroscience & …, 2022 - Elsevier
This network meta-analysis compared the short-term treatment effects of different
antidepressants on depression severity and HbA1c in depressed patients with type 2 …